Struggling Teva Wants To Overhaul Board By Nominating 4 New Directors

Published: Jun 09, 2017

Teva Pharmaceutical Industries Ltd. will seek to overhaul its board by nominating four new directors, the latest step toward remaking the struggling drug company.

Teva, the world's biggest seller of low-price generic drugs, will ask shareholders to approve the nominees at the company's annual meeting July 13, said Sol Barer, the board's chairman. The nominees would replace longtime board members who have decided to step aside or aren't seeking new terms.

Back to news